InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Life Sciences IP Focus 2012

  • Editorial

  • Interview: Robert Armitage, Eli Lilly

    The American Invents Act could have a big effect on the life sciences industry. Kevin Matha spoke with Robert A Armitage, senior vice president and general counsel at Eli Lilly, about the new legislative package

  • Interview: Looking back on decades of industry change

    Tom Ciotti and Kate Murashige of Morrison & Foerster have been involved with the life sciences industry for almost 50 years. Phillip Bausk spoke with them about the changes they have seen in that time

  • Europe: Patenting plant breeding

    Edward J Farrington of Inspicos considers the role of human intervention when acertaining the limits of patentability in plant breeding

  • Europe: Selection inventions

    Louise Tottie and Anette Romare of Valea outline important aspects of selection inventions relating to lists and ranges, to consider when drafting patent applications

  • Mexico: New practice on medical-use claims

    Agustín Azcatl, Daniel Sánchez and Pedro Herrera of Olivares & Cia explain the impact of rule changes on first medical-use claims

  • US: The America Invents Act

    Ha Kung Wong and John Kirkland of Fitzpatrick Cella Harper & Scinto use three scenarios to examine the impact of the Act and the future of paragraph IV litigation


profile

Managing IP

ManagingIP

ManagingIP profile

Graphics showing what patent protection will cost in Europe, post- #unitarypatent ($/trial) http://t.co/EClJx919gW http://t.co/GBc0XfX2yz

Jul 3 2015 02:28 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @The_IPO: Do you work in #mediarelations or know someone who does? @The_IPO have a vacancy in our #London office http://t.co/SkHPfN2yIY

Jul 3 2015 01:48 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @OAMITWEETS: Our webinar programme for July 7 http://t.co/CbPXRi0ITB

Jul 3 2015 11:45 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


INTA Daily News 2015

Read this year's INTA Daily News - published daily by Managing IP direct from the INTA Annual Meeting in San Diego


June 2015

The fine line between abuse and fair use at the PTAB

Hedge fund manager Kyle Bass has outraged the pharma and biotech industries by seeking to invalidate their patents at the PTAB, with some observers linking his attacks to short-selling of company stocks. Michael Loney reports on a controversy that goes to the heart of the US patent system



Most read articles

Supplements